Breast Cancer Research and Treatment

VOL. 53, No. 1, January 1999


Reports
Applying the Nottingham Prognostic Index to a Swedish breast cancer population
M Sundquist, S Thorstenson, L Brudin, Bo Nordenskjold, the South East Swedish Breast Cancer
Study Group 1-8

Loss ofheterozygosity in BRCAI and BRCA2 markers and high-grade malignancy in breast cancer
JM Silva, R Gonzalez, M Provencio, G Dominguez, JM Garcia, I Gallego, J Palacios, P Espana, F
Bonilla 9-17

The methodology of quantitation of microvessel density and prognostic value of neovascularization
associated with long-term survival in Japanese patients with breast cancer
T Kato, T Kimura, N Ishii, A Fujii, K Yamamoto, S Kameoka, T Nishikawa, T Kasajima 19-31

Analyses of microsatellite instability and the transforming growth factor-B receptor type II gene mutation
in sporadic breast cancer and their correlation with clinicopathological features
S Tomita, S Deguchi, T Miyaguni, Y Muto, T Tamamoto, T Toda 33-39

Antisense oligonucleotides to the epidermal growth factor receptor
L Witters, R Kumar, M Mandal, CF Bennett, L Miraglia, A Lipton 41-50

Quantitative changes in cytological molecular markers during primary medical treatment of breast
cancer: A pilot study
A Makris, TJ Powles, DC Allred, SE Ashley, PA Trott, MG Ormerod, JC Titley, M Dowsett 51-59

p53 expression in breast and endometrium during estrogen and tamoxifen treatment of surgically
postmenopausal cynomolgus macaques
E Isaksson, JM Cline, L Skoog, G Soderqvist, N Wilking, E von Schoultz, B von Schoultz 61-67

Development of a knowledge scale about breast cancer and heredity (BCHK)
N Ondrusek, E Wamer, V Goel 69-75

Predictive chemotherapy of advanced breast cancer directed by MTT assay in vitro
J-M Xu, S-T Song, Z-M Tang, Z-F Jiang, X-Q Liu, L Zhou, J Zhang, X-W Liu 77-85

Brief communication
Male breast cancer in the hereditary nonpolyposis colorectal cancer syndrome
J Boyd, E Rhei, MG Federici, PI Borgen, P Watson, B Franklin, B Karr, J Lynch, SJ Lemon, HT
Lynch 87-91

Announcement 93

Instructions for authors 95-96


_______________________________________

Breast Cancer Research and Treatment

VOL. 53, No. 2, January 1999


Review
Sentinel lymphadenectomy in breast cancer: identification of sentinel lymph node and detection of
metastases
M Noguchi, K Tsugawa, E Bando, F Kawahara, K Miwa, K Yokoyama, K Nakajima, N Tonami 97-104


Reports
Prognostic factors in patients with isolated recurrences of breast cancer (stage IV-NED)
0 Juan, A Lluch, L de Paz, F Prosper, P Azagra, I Marugan, A Martfnez-Agullo, J Garcia-Conde 105-112

Combined effect of vitamin DJ analogs and paclitaxel on the growth of MCF-7 breast cancer
cells in vivo
K Koshizuka, M Koike, H Asou, SK Cho, T Stephen, RK Rude, L Binderup, M Uskokovic, HP
Koeffler 113-120

Human papillomavirus 16 in breast cancer of women treated for high grade cervical intraepithelial
neoplasia (CIN III).
EM Hennig, Z Suo, S Thoresen, R Holm, S Kvinnsland, JM Nesland 121-135

The declining use of axillary dissection in patients with early stage breast cancer
XDu.JL Freeman, JSGoodwin 137-144

Effect of fenretinide on bone mineral density and metabolism in women with early breast cancer
A Decensi, R Torrisi, A Gozza, G Severi, G Bertelli.V Fontana, F Pensa, L Carozzo, A Traverse,
SMilone,DDini,ACosta 145-151

Comparative effect of chlormadinone acetate and diethylstilbestrol as promoters in mammary tumori-
genesis of rats irradiated with y -rays during lactation
H Inano, K Suzuki, M Onoda, H Kobayashi, K Wakabayashi 153-160

Serum VEGF levels in women with a benign breast tumor or breast cancer
P Salven, V Perhoniemi, H Tykka, Hanna Maenpaa, H Joensuu 161-166

Expression of epidermal growth factor receptor mRNA and protein in primary breast carcinomas
RA Walker, SJ Dearing 167-176

The expression of variant exon v7-v8 CD44 antigen in relation to lymphatic metastasis of human breast
cancer
J Kinoshita, S Haga, T Shimizu, H Imamura, 0 Watanabe, T Kajiwara 177-183

Effect of thermal variables on human breast cancer in cryosurgery
J Rui, KN Tatsutani, R Dahiya, B Rubinsky 185-192

Announcement Susan G. Komen Breast Cancer Foundation 193-196

Instructions for authors 197-198

_______________________________________

Breast Cancer Research and Treatment

VOL. 54, No. 1, March 1999


Review
BRCAI and BRCA2 in breast cancer
XYang,MELippman 1-10

Reports
IGF-I and retinoic acid regulate the distribution pattern ofIGFBPs synthesized by the canine mammary
tumor cell line CMT-U335
MA Oosterlaken-Dijksterhuis, MM Kwant, A Slob, E Hellmen, JA Mol 11-23

Risk factors for a decline in upper body function following treatment for early stage breast cancer
RA Silliman, MN Prout, T Field, SC Kalish, T Colton 25-30

Methodological arguments for the necessity of randomized trials in high-dose chemotherapy for breast
cancer
C Schmoor, M Schumacher 31-38

Synergistic cooperation between c-Myc and Bcl-2 in lymph node progression of T1 human breast
carcinomas
A sierra, X Castellsague, A Escobedo, A Moreno, T Drudis, A Fabra 39-45

Quality of life in women with recurrent breast cancer
AA Bull, BE Meyerowitz,S Hart, PMosconi.G Apolone, A Liberati 47-57

Reduced telomere DNA content is correlated with genomic instability and metastasis in invasive human
breast carcinoma
JK Griffith, JEBryant,CAFordyce,FDGilliland,NEJoste,RKMoyzis 59-64

Tumor flow in malignant breast tumors measured by Doppler ultrasound: an independent predictor of
survival
CPeters-Engl.W Frank, SLeodolter,MMedl 65-71

Prognosis, treatment, and recurrence of breast cancer for women attending or not attending the
Screening Mammography Program of British Columbia
lAOlivotto.D Mates, LKan,JFung,RSamant,LJWBurhenne 73-81

Analyzing prognostic factors in breast cancer using a multistate model
P Broet, ADL Rochefordiere, SM Scholl, A Fourquet, YD Rycke, P Pouillart, V Mosseri, B Asselain 83-89

Instructions for authors 91-92

_______________________________________

Breast Cancer Research and Treatment

VOL. 54, No. 2, March 1999


Reports
Reversal of estrogen-resistance in murine mammary adenocarcinomas
MF Montecchia, A Molinolo, C Lanari 93-99
The additionally glycosylated variant of human sex hormone-binding globulin (SHBG) is linked to
estrogen-dependence of breast cancer

M Becchis, R Frairia, P Ferrera, A Fazzari, S Ondei, A Alfarano, C Coluccia, N Biglia, P Sismondi,
N Fortunati 101-107
Quality of life in patients with ductal carcinoma in situ of the breast treated with conservative surgery
and postoperative irradiation

M Arnichetti, 0 Caffo, M Arcicasa, M Roncadin, 0 Lora, A Rigon, G Zini, L Armaroli, F Coghetto,
PZorat,SNeri,NTeodorani 109-115
Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with metastatic breast
cancer. An updated analysis

PP Peethambaram, JN Ingle, VJ Suman, LC Hartmann, CL Loprinzi 117-122
Vitamin 03 receptor (VDR) expression in HC-II mammary cells: regulation by growth-modulatory
agents, differentiation, and Ha-ras transformation

MTF Escaleira, MM Brentani 123-133
De-regulation of GRP stress protein expression in human breast cancer cell lines

GGazit.JLu.ASLee 135-146
Invasion marker PAI-I remains a strong prognostic factor after long-term follow-up both for primary
breast cancer and following first relapse

NHarbeck,CThomssen,UBerger,KUIm, RE Kates, HH5fler,FJanicke,HGraeff,MSchmitt 147-157
Tumour necrosis factor-a interleukin-I and -6 in fibrocystic breast disease

A Herruzo, JA Castilla, A Ramfrez, C Marcos, S Menjon 159-164
Dose intensification of mitoxantrone in combination with paclitaxel in advanced breast cancer: a phase
II study

FD Costanzo, A Sdrobolini, L Manzione, D Bilancia, L Acito, S Gasperoni, L Valenti, L Fioriti,
S Angiona, L Giustini 165-171
Constitutive activation of pp 125(fak) in newly isolated human breast cancer cell lines
KMW Ignatoski, SP Ethier

Breast Cancer Research and Treatment

VOL. 55, No. 3, June 1999

Reports

Treatment of advanced breast cancer with gerncitabine and vinorelbine plus human granulocyte colony-
stimulating factor
K Haider, 0V Kornek, W Kwasny, G Weinlander, J Valencak, F Lang, F Piiribauer,'
E Kovats, D Depisch, W Scheithauer 203-211

Identification of families with hereditary breast and ovarian cancer for clinical and mammographic
surveillance: the Modena Study Group proposal
M Federico, A Maiorana, L Mangone, D T\irchetti, B Canossi, L Cortesi, R Romagnoli, V Silingardi 213-221

Mechanism of captopril toxicity to a human mammary ductal carcinoma cell line in the presence of
copper
W Small, Jr, A Molteni, YT Kirn, JM Taylor, C Ts'ao, WF Ward 223-229

Induction of insulin-like growth factor binding protein expression by ICI 182,780 in a tamoxifen-
resistant human breast cancer cell line
JP Parisot, KS Leeding, XF Hu, M DeLuise, JR Zaicberg, LA Bach 231-242

A study on the cost effectiveness of sestamibi scintimammography for screening women with dense
breasts for breast cancer
MW Alien, PHendi,LBassett, ME Phelps,SSGambhir 243-258

Breast cancer and timing of surgery during menstrual cycle: a 5-year analysis of 248 premenopausal
women
M Milella, C Nistico, V Ferraresi, A Vaccaro, A Fabi, AM D'Ottavio, C Botti, D Giannarelli, M
Lopez, E Cortesi, CM Foggi, M Antimi, E Terzoli, F Cognetti, P Papaldo 259-266

Constitutive overexpression of cyclin Di in human breast epithelial cells does not prevent GI arrest
induced by deprivation of epidermal growth factor
J-LChou,ZFan,TDeBlasio,AKoff,NRosen,JMendelsohn 267-283

Early age at menopause and breast cancer: are leaner women more protected? A prospective analysis
of the Dutch DOM cohort
EM Monninkhof, YT van der Schouw, PHM Peeters 285-291
Letter to the Editor
JR Benson, MP Osbome 293

Author index 295-296

Subject index 297-300

Instructions for authors 301-302